Lispro insulin (HUMALOG) in practice;L'insuline lispro (HUMALOG) en prathique

Diabetes and Metabolism

Volumn 24, Issue 3, 1998, Pages 272-275

  Selam, J L ^a   Slama, G ^b  

^a HÔTEL DIEU   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN LISPRO;

DIABETES MELLITUS; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; HUMAN; HYPERGLYCEMIA; NOTE;

DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN;

EID: 0031839644     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (21)

1. Selam JL. Du concept des analogues rapides aux propriétés de l'insuline lispro. Diabète & Métabolisme, 1997, 23, 1-5.
2. Holleman F, Hoekstra JB. Insulin lispro. N Engl J Med, 1997, 337, 176-183.
3. Berger M, Heinemann L. Are presently available insulin analogues clinically beneficial ? Diabetologia, 1997, 40, S91-S96.
4. Demirjian S, Bardin C, Zirinis P, Slama G, Chast F, Selam JL. Lispro insulin is suitable for external but nor for implantable pumps. Diabetes (sous presse).
5. Zinman B, Thildesley H, Chiasson JL, Tsui E, Strack T. Insulin lispro in CSII. Results of a double-blind crossover study. Diabetes, 1997, 46, 440-443.
6. Torri M, Scavini M, Dozio N, Petrella G, Galimberti G, Pozza G. Pharmacokinetics of insulin analogue Lys (B28) Pro (B29) following intra-peritoneal administration, (abstract). Diabetes, 1995, 44, suppl. 1, 130A.
7. Ter Braak EW, Woodworth JR, Bianchi R. et al. Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin. Diabetes Care, 1996, 19, 1437-1440.
8. Fineberg NS, Fineberg SE, Anderson JH, Birkett MA, Gibson RG, Hufferd S. Immunologic effects of insulin lispro [Lys(B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin. Diabetes, 1996, 45, 1750-1754.
9. Hermoso F, Vazquez M, Chares G, Reviriego J, Andion R. Generalized allergy to human insulin treated with insulin lispro, (abstract). Diabetologia, 1997, 40 (suppl. 1), A349.
10. Henrichs HR, Unger H, Trautman ME, Pfutzner A. Severe insulin resistance treated with insulin lispro. Lancet, 1996, 348, 1248.
11. Ahmed AME, Home PD. Reduced nocturnal hypoglycaemia with insulin analogue lispro in type 1 diabetic patients, (abstract). Diabetologia, 1997, 40 (suppl. 1), A10.
12. Heller SR, Amiel SA, Janes J. Hypoglycemia during intensive insulin therapy : a comparison of lispro and regular insulin. Diabetes, 1997, 46, (suppl. 1), 0581.
13. Hanaire H, Bringer J, Lassman-Vague V, et al: Improvement of HbA1c without increasing hypoglycemia risk in diabetic patients treated with insulin lispro in external pumps, (abstract). Diabetologia, 1997, 40 (suppl. 1), A10.
14. Anderson JH, Brunelles RL, Koivisto VA. et al. and the Multicenter Insuli Lispro Study Group. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes, 1997, 46, 265-270.
15. Pfutzner A, Kûstner E, Forst T. et al, on behalf of the German Insulin Lispro/IDDM study group: Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes. Exp Clin Endocrinol, 1996, 104, 25-30.
16. Jacobs M.A.J.M, Salobir B, Popp-Snidjers C, Ader H, Heine RJ. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys (B28), Pro (B29) human insulin analogue (insulin lispro) in healthy mal volunteers. Diabetic Medicine, 1997, 14, 248-257.
17. Diamond T, Kormas N. Possible adverse fetal effect of insulin lispro. New Engl J Med, 1997, 337, 1009.
18. Anderson H, Bastyr E, Wishner K. - Reply -, New Engl J Med, 1997, 337, 1010.
19. Schernthaner G, Wein W, Sandholzer K, Equiluz-Bruck S, Birkett M. Postprandial use of insulin lispro: a new therapeutic option in the treatment of type 1 diabetic patients, (abstract). Diabetologia, 1996, 39 (suppl. 1), A24.
20. Ronnemaa T, Viikari J. Reduction of snacks when switching IDDM patients from regular insulin to lispro insulin, (abstract). Diabetologia, 1997, 40 (suppl. 1), A350.
21. Tuominen JA, Karonene SL, Melamies L, Bolli G, Koivistol VA. Exercise-induced hypoglycaemia in IDDM patients treated with a short-acting insulin analogue. Diabetologia, 1995, 38, 106-111.